Home
PermaFix Medical
Overview
Technology
Value Proposition
Isotope Market
Perma-Fix R&D
Grant Funding
Investor Information
Corporate Profile
Financial Highlights
Stock Quotes
Management Board
Supervisory Board
Shareholder Structure
Shares
Calendar
Current Reports
EBI
ESPI
Financial Reports
Events / Conference Calls
Prospectuses
Corporate Documents
General Meetings of Shareholders
Presentations
Press Releases
Contact for Investors
Contact Us
Investor Information
Financial Reports
Q1
Q2
Q3
Q4
ANNUAL
2013
ANNUAL
2014
Q1'2014
Q2'2014
Q3'2014
Q4'2014
SEPERATE
/
CONSOLIDATED
2015
Q1'2015
Q2'2015
Q3'2015
Q4'2015
SEPERATE
/
CONSOLIDATED
2016
Q1'2016
Q2'2016
Q3'2016
Q4'2016
SEPERATE
/
CONSOLIDATED
2017
Q1'2017
Q2'2017
Q3'2017
Q4'2017
SEPERATE
/
CONSOLIDATED
2018
Q1'2018
Q2'2018
Q3'2018
Q4'2018
SEPERATE
/
CONSOLIDATED
2019
Q1'2019
Q2'2019
Q3'2019
Q4'2019
SEPERATE
/
CONSOLIDATED
2020
Q1'2020
Q2'2020
Q3'2020
Q4'2020
SEPERATE
/
CONSOLIDATED
2021
Q1'2021
Q2'2021
Q3'2021
Q4'2021
ANNUAL
2022
Q1'2022
Q2'2022
Q3'2022
Financial reports are available only in Polish